The article deals with the results of operations performed on 306 patients for extirpation of the esophagus and one-stage total esophagoplasty with the formation of the anastomosis on the neck. The operation was conducted on 178 patients with carcinoma and 128 patients with benign esophageal strictures. The authors claim this operation to be the operation of choice in esophageal carcinoma, cardioesophageal carcinoma, burn and peptic strictures, and in patients with stage IV cardiospasm. An isoperistaltic gastric tube or the large intestine is used for replacement of the esophagus. The postoperative mortality rate was 3.3%. The immediate and late-term results of this operation are much better than those of the other types of esophagoplasty. The authors recommend the operation to be used widely in the practice of specialized clinics for the management of the above mentioned diseases.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
[Efficacy and feasibility of tunnel esophagogastrostomy to perform proximal gastrectomy].
Zhonghua Wei Chang Wai Ke Za Zhi
October 2024
Department of General Surgery, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, the Affiliated Cancer Hospital of Nanjing Medical University, Nanjing 210009, China.
Article Synopsis
- The study assesses the effectiveness and practicality of a new surgical technique called tunnel esophagogastrostomy for patients undergoing proximal gastrectomy, involving 10 male patients aged around 64 on average.
- All patients had specific types of gastric adenocarcinoma, with varying TNM stages, and the procedure was completed without major complications, regardless of surgery type (laparoscopic, robotic, or open).
- Key metrics indicated a mean operation time of approximately 213 minutes, a hospital stay of about 9 days, and no serious postoperative complications, suggesting this technique's safety and viability in clinical settings.
Acquired tracheoesophageal fistula repaired with one-stage surgery without tracheal resection using lateral cervical approach, a case report.
Int J Surg Case Rep
June 2024
Research Office, King Abdullah International Medical Research Centre, Ministry of National Guard Health Affairs, Jeddah 22384, Saudi Arabia; College of Medicine, King Saud Bin Abdulaziz University for Health Science, Jeddah 22384, Saudi Arabia. Electronic address:
Introduction: Acquired non-malignant tracheoesophageal fistula (TEF) is a rare pathological connection between the trachea and esophagus caused primarily by iatrogenic injuries. Cuff-related injury causes pressure necrosis of the tracheoesophageal walls, often due to the overinflation of tubes.
Presentation Of Case: A 29-year-old male who was mechanically ventilated for 3 months developed TEF after weaning from ventilation.
Simultaneous type III congenital esophageal atresia and patent ductus arteriosus in a low-weight patient: A case report.
World J Clin Cases
January 2024
Department of Cardiothoracic Surgery, Kunming Children's Hospital, Kunming 650103, Yunnan Province, China.
Background: We report a low-birth-weight child (1.8 kg) with neonatal type III congenital esophageal atresia (CEA) combined with symptomatic patent ductus arteriosus (PDA). After comprehensive evaluation, esophageal anastomosis was performed on postnatal day 11 after excluding surgical contraindications, and arterial catheter ligation was performed at the same time.
View Article and Find Full Text PDFUse of Staged vs. Primary Repair in Thoracoscopic Esophageal Atresia Repair.
J Pediatr Surg
March 2024
Department of Pediatrics, Hematology and Oncology, Collegium Medicum, Nicolaus Copernicus University in Torun, Bydgoszcz, Poland.
Introduction: Morbidity after thoracoscopic primary repair of esophageal atresia (EA) is still high in many centers. We retrospectively assessed the outcomes of a center-specific standardized approach in a group of newborns with EA that had been classified into one of two surgical management groups.
Methods: 38 consecutive newborns with EA (median birth weight: 2570 g, range: 1020-3880) were treated between 2013 and 2022.
Prognostic implications of the extent of downstaging after neoadjuvant therapy for oesophageal adenocarcinoma and oesophageal squamous cell carcinoma.
BJS Open
May 2023
Northern Oesophagogastric Unit, Royal Victoria Infirmary, Newcastle University Trust Hospitals, Newcastle upon Tyne, UK.
Background: There are few data evaluating the extent of downstaging in patients with oesophageal adenocarcinoma and oesophageal squamous cell carcinoma and the difference in outcomes for a similar pathological stage in neoadjuvant-naive patients. The aim of this study was to characterize the prognostic value of downstaging extent in patients receiving neoadjuvant therapy for oesophageal cancer.
Methods: Oesophageal adenocarcinoma and oesophageal squamous cell carcinoma patients receiving either neoadjuvant chemotherapy or neoadjuvant chemoradiotherapy between 2004 and 2017 were identified from the National Cancer Database.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!